data-driven vaccine design platform
baseimmune is a biotech startup founded to create the next generation of vaccines. Our unique platform is based on innovative and powerful technology which is able to generate antigens using a level of informatics depth not previously seen.
Using this approach we are able to tackle emerging and challenging pathogens that had been failed by traditional approaches and importantly able to ensure our vaccines remain effective even if a pathogen mutates.
As a discovery phase biotech, we offer our antigen discovery services and develop broad-spectrum vaccines against highly variable pathogens.
We utilise deep-learning techniques to monitor pathogen dynamics, predicting forthcoming changes in emerging pathogens and generate vaccines which are effective against all current and future unknown strains
Our technologies are based on a data-driven platform for the analysis of pathogen genomics, proteomics, epidemiology, evolution and clinical data. Targeted at the faster and cheaper development of effective and safe rationally designed vaccines.
With talented vaccine experts, scientists, bioinformaticians and software engineer in the field, baseimmune is committed to translating ‘OMICs’ big-data into real-world solutions. By collaborating with leading institutions and companies and an expert panel of scientific advisors, we hope to develop vaccines and reduce the burden of infectious diseases in human and animal health.
The baseimmune pipeline currently focuses on major challenges in infectious diseases. We are building a unique pipeline to address veterinary and human threats worldwide.
Our bespoke antigen discovery platform allied with superior vaccine delivery systems, allow us to fast track the discovery phase of vaccines and move faster to preclinical pipeline.
Working with world-class research institutes
We are funded and supported by the Innovate UK, the UK Innovation and Science fund and the KQ labs accelerator.
© 2020 baseimmune. All rights reserved